EP3703818
IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.10.2018EP published:
1.11.2023EP application number:
18799655.8
EPO information:
European Patent Register
Max expiry date:
28.10.2038
Title in English:
IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMALanguage of the patent:
English
Timeline
Today
29.10.2018EP application
1.11.2023EP Publication
Owner
Name:
Sanofi BiotechnologyAddress:
82 Avenue Raspail, 94250 Gentilly, FR
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
AMIN, NikhilAddress:
Chappaqua New York 10514, US
Name:
GRAHAM, NeilAddress:
Croton-On-Hudson New York 10520, US
Name:
PIROZZI, GianlucaAddress:
Bridgewater New Jersey 08807, US
Name:
TEPER, ArielAddress:
Bridgewater New Jersey 08807, US
Priority
Number:
201762579120 PDate:
30.10.2017Country:
US
Number:
201862710381 PDate:
16.2.2018Country:
US
Number:
201862647368 PDate:
23.3.2018Country:
US
Number:
18305566Date:
4.5.2018Country:
EP
Number:
201862742736 PDate:
8.10.2018Country:
US
Classification
Categories:
A61P 11/06, A61K 39/395